In diabetic nephropathy induced with streptozotocin, resveratrol increases CPT1 and PPARα inhibiting mTOR (Li 2020) and AMPKα (Zhao 2020) autophagy pathways and reduces ROS increasing antioxidant enzymes (Salami et al. 2022). This evidence concerns the gene CPT1A and diabetic kidney disease.